Genotypic Detection of Antibiotic Resistant Bacteria and Genes

Antibiotic or antimicrobial resistance has emerged as one of the most consequential challenges confronting modern medicine, agriculture, and public health. The increasing prevalence of bacterial pathogens that withstand previously effective antimicrobial agents threatens the management of infectious diseases and complicates clinical decision-making. Conventional approaches to detecting antibiotic resistance frequently depend on phenotypic susceptibility testing, in which bacterial growth is assessed in the presence of selected antibiotics. Although these methods remain indispensable, they may require substantial incubation time and can occasionally fail to reveal resistance mechanisms before therapeutic decisions must be made. Genotypic detection provides a complementary strategy by examining the genetic determinants that underpin antimicrobial resistance (AMR).

Genotypic detection of antibiotic-resistant bacteria involves identifying specific genes, mutations, or genetic alterations associated with resistance. These determinants may encode antibiotic-inactivating enzymes, modified antimicrobial targets, altered membrane permeability, or active efflux systems. Important resistance-associated genes include those responsible for extended-spectrum β-lactamases, carbapenemases, methicillin resistance, vancomycin resistance, and aminoglycoside-modifying enzymes. Rather than observing resistance as a physiological outcome, molecular approaches seek to identify its genetic basis directly, potentially enabling recognition of resistant organisms before conventional culture-based susceptibility results become available.

The development of molecular diagnostics has substantially expanded the capacity to investigate bacterial resistance at the genomic level. Polymerase chain reaction (PCR), multiplex PCR, real-time PCR, DNA sequencing, microarray technologies, and whole-genome sequencing can detect resistance-associated genetic signatures with varying degrees of sensitivity, specificity, speed, and resolution. These techniques also provide opportunities to distinguish between closely related resistance mechanisms and to investigate the genetic context in which resistance determinants occur. In particular, whole-genome sequencing can reveal a broader resistome, including multiple resistance genes, chromosomal mutations, and mobile genetic elements that may facilitate horizontal transmission between bacterial populations.

An important feature of genotypic detection is its potential to support earlier and more targeted antimicrobial interventions. Rapid identification of resistance determinants can assist clinicians in selecting appropriate therapies, reducing unnecessary exposure to ineffective antibiotics and potentially limiting the transmission of resistant strains. Beyond clinical diagnosis, molecular surveillance can facilitate the monitoring of resistance patterns across hospitals, communities, food-production systems, and environmental reservoirs.

Nevertheless, the presence of a resistance gene does not invariably correspond to phenotypic resistance, because gene expression, regulatory mechanisms, bacterial background, and other biological factors can influence the observed phenotype. Genotypic approaches are most informative when interpreted alongside microbiological and epidemiological evidence. Continued advances in molecular diagnostics and genomic analysis therefore offer an increasingly precise framework for understanding, detecting, and monitoring antibiotic resistance, while also creating new possibilities for timely intervention against resistant bacterial populations.

Molecular basis and diagnostic significance of genotypic detection of AMR genes

The genotypic detection and characterization of antibiotic resistance genes in pathogenic bacteria provides a molecular approach for identifying the genetic determinants responsible for antimicrobial resistance. Unlike phenotypic detection, which evaluates the observable response of a bacterial isolate to particular antibiotics, genotypic methods investigate the underlying nucleic acid sequences associated with resistance. The term genotypic is derived from genotype, referring to the genetic constitution of an organism. Genotypic detection focuses on identifying specific DNA or RNA sequences that encode, regulate, or contribute to antimicrobial resistance.

Genotypic techniques are fundamentally DNA-based molecular methods, whereas conventional phenotypic approaches are primarily dependent on bacterial growth and antibiotic–organism interactions. Phenotypic antimicrobial susceptibility testing remains essential for determining whether an organism is susceptible, intermediate, or resistant to a particular antimicrobial agent; however, it does not necessarily reveal the precise genetic mechanism responsible for the observed phenotype. Molecular characterization therefore adds an important layer of information by identifying resistance genes and, in some cases, the mutations or genetic structures associated with their expression and dissemination.

A major advantage of genotypic detection is its ability to identify resistance determinants (genes) directly from bacterial isolates, and in some diagnostic settings, directly from clinical specimens. This can facilitate the rapid recognition of clinically important genes encoding mechanisms such as β-lactamase production, target modification, enzymatic drug inactivation, and active antimicrobial efflux. Molecular results can consequently complement phenotypic susceptibility profiles and assist in understanding discrepancies between genotype and phenotype. The detection of a resistance gene should not automatically be interpreted as proof of phenotypic resistance, since gene expression, regulatory mechanisms, bacterial genetic background, and other biological factors can influence the final phenotype.

Several DNA-based techniques have been developed for the detection and characterization of antimicrobial resistance determinants. Polymerase chain reaction (PCR) is among the most widely applied approaches because it enables selective amplification of specific genetic targets. Other techniques include restriction fragment length polymorphism (RFLP), PCR-single-stranded conformation polymorphism (PCR-SSCP), random amplified polymorphic DNA (RAPD), fluorescent in situ hybridization (FISH), DNA microarrays, ligase chain reaction (LCR), and nucleotide sequencing. More advanced sequencing approaches, particularly whole-genome sequencing, can provide comprehensive information about multiple resistance determinants and their genetic contexts within bacterial genomes.

In PCR-based detection, primers designed to recognize a particular resistance-associated sequence are used to amplify the target DNA. The reaction involves repeated cycles of denaturation, primer annealing, and extension, resulting in exponential amplification of the target sequence. Following amplification, PCR products may be separated by agarose gel electrophoresis and examined for DNA fragments of the expected size. A molecular marker or DNA ladder is run alongside the samples to provide reference fragment sizes. Visualization of a band corresponding to the anticipated size supports the presence of the targeted genetic sequence, although definitive characterization may require additional methods such as sequencing.

Modern molecular diagnostics increasingly combine amplification-based detection with sequencing and bioinformatic analysis, enabling not only identification of resistance genes but also investigation of their variants, mutations, and potential mobility. Thus, genotypic detection represents an important molecular framework for defining the genetic basis of antibiotic resistance and strengthening surveillance, diagnosis, and characterization of resistant pathogenic bacteria.

Molecular and genotypic techniques for the detection of AMR genes

The detection of AMR at the molecular and genetic level provides important information about the mechanisms that enable pathogenic bacteria to survive antimicrobial exposure. Unlike conventional antimicrobial susceptibility testing (AST), which primarily measures the observable growth response of bacteria to antibiotics, genotypic approaches investigate the genetic determinants, mutations, and molecular signatures associated with resistance. These techniques can identify resistance genes more rapidly and, in some cases, before a detectable phenotypic resistance pattern has developed. They are therefore increasingly important in clinical diagnosis, epidemiological surveillance, infection control, antimicrobial stewardship, and research into the evolution and transmission of resistant organisms.

Molecular AMR detection encompasses a broad spectrum of technologies, ranging from targeted amplification techniques such as PCR to high-throughput approaches such as next-generation sequencing and metagenomics. Other emerging platforms combine molecular recognition with biosensors, microfluidics, CRISPR-based detection, mass spectrometry, and computational analysis. The choice of technique depends on the organism, resistance mechanism, specimen type, required turnaround time, available resources, and whether the objective is to detect a specific resistance gene or characterize the broader resistome. Importantly, molecular detection complements rather than universally replaces phenotypic AST because the presence of a resistance determinant does not always predict its expression or the complete antimicrobial susceptibility phenotype.

Major molecular and genotypic techniques used in AMR gene detection are as follows:

• Nucleic Acid Amplification Technology (NAAT)

• Polymerase Chain Reaction (PCR)

• Multiplex PCR

• Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

• Real-Time Polymerase Chain Reaction (qPCR)

• Digital PCR (dPCR)

• PCR-Restriction Fragment Length Polymorphism (PCR-RFLP)

• Restriction Fragment Length Polymorphism (RFLP)

• Single-Strand Conformational Polymorphism (SSCP)

• Random Amplified Polymorphic DNA (RAPD)

• Ligase Chain Reaction (LCR)

• Isothermal Amplification Methods

• Next-Generation Sequencing (NGS)

• Whole-Genome Sequencing (WGS)

• Nanopore Sequencing

• Metagenomics for Antimicrobial Surveillance

• DNA Microarray

• Fluorescence In Situ Hybridization (FISH)

• Mass Spectrometry-Based Methods

• Bioinformatics Approaches for AMR Gene Detection

• AMR Gene Databases

• Microfluidics

• Biosensors and Nanotechnology

• AST Optical Biosensors

• AST Electrochemical Biosensors

• CRISPR-Cas-Based Detection

• Integration of CRISPR-Cas Systems with Aptamers

• Machine Learning and Predictive Analytics

• Molecular AST Platforms

• Genomic Variant and Mutation Analysis

These techniques demonstrate the transition from conventional resistance testing toward molecularly resolved AMR surveillance. Targeted methods such as PCR remain valuable for rapid detection of established resistance genes, whereas sequencing, metagenomics, and bioinformatics provide broader characterization of the resistome and its genetic context. Emerging technologies such as biosensor, CRISPR, microfluidic, and machine-learning technologies may further expand the speed, portability, and analytical scope of AMR detection.

1. Nucleic Acid Amplification Technology (NAAT) in AST

Nucleic Acid Amplification Technology (NAAT) comprises molecular techniques used to amplify and detect specific DNA or RNA sequences associated with antimicrobial resistance (AMR). In AMR detection, NAAT can identify resistance genes directly or from cultured bacterial isolates, providing results faster than many conventional culture-based approaches. NAAT is particularly valuable when rapid recognition of resistance is clinically important. Depending on the platform, it may include PCR-based or isothermal amplification methods. Its major advantages include high analytical sensitivity, specificity, and the ability to target clinically important resistance determinants.

2. Polymerase Chain Reaction (PCR)

Polymerase Chain Reaction (PCR) is one of the most widely used molecular techniques for detecting antimicrobial resistance genes. The method selectively amplifies a specific DNA sequence using primers complementary to the target region. Through repeated cycles of denaturation, annealing, and extension, the target sequence is exponentially amplified to detectable levels. PCR can identify genes encoding important resistance mechanisms, including β-lactamases, aminoglycoside-modifying enzymes, and other resistance determinants. Its speed, sensitivity, specificity, relatively simple workflow, and adaptability to different targets make PCR an important tool in AMR diagnosis and surveillance.

3. Multiplex PCR

Multiplex PCR is a modified PCR technique that allows several DNA targets to be amplified simultaneously within a single reaction. In AMR investigations, multiple primer pairs can be designed to detect different resistance genes at the same time. This approach is useful when bacterial isolates may carry several resistance determinants or when simultaneous screening for multiple clinically significant genes is required. Multiplex PCR can reduce reagent consumption, processing time, and workload compared with performing separate reactions for each target. However, careful primer design and optimization are required to minimize interference between reactions.

4. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is primarily used when the genetic material of interest is RNA. During the initial stage, reverse transcriptase converts RNA into complementary DNA (cDNA), which is subsequently amplified using PCR. In AMR research, RT-PCR can investigate the transcription or expression of resistance-associated genes and determine whether particular resistance determinants are actively transcribed. This distinction is valuable because the mere presence of a resistance gene does not necessarily indicate that it is expressed. RT-PCR therefore provides additional information concerning the functional activity of resistance-associated genetic determinants.

5. Real-Time Quantitative Polymerase Chain Reaction (qPCR)

Real-Time Polymerase Chain Reaction (RT-qPCR) combines DNA amplification with fluorescence-based detection, allowing the accumulation of amplified products to be monitored throughout the reaction. In AMR detection, qPCR can rapidly identify specific resistance genes and, depending on the assay design, estimate the quantity of target nucleic acid present. Fluorescent dyes or sequence-specific probes generate signals proportional to amplification. Unlike conventional PCR, qPCR generally does not require post-amplification gel electrophoresis for detection. Its speed, sensitivity, specificity, and capacity for multiplexing make it useful for clinical diagnostics, surveillance, and quantitative investigation of AMR determinants.

6. Digital PCR (dPCR)

Digital PCR (dPCR) is a highly sensitive nucleic acid amplification technique in which a sample is divided into a large number of individual reaction partitions. Following amplification, partitions are classified as positive or negative for the target sequence, allowing absolute quantification without relying on conventional calibration curves. In AMR research, dPCR can detect and quantify low-abundance resistance genes that may be difficult to measure using conventional PCR. It can also support precise assessment of gene copy numbers in bacterial, environmental, and clinical samples. Its high sensitivity makes it particularly useful for surveillance and research applications.

7. PCR Combined with Restriction Fragment Length Polymorphism (PCR-RFLP)

PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) combines targeted PCR amplification with restriction-enzyme digestion to investigate genetic variation. First, a specific DNA region associated with an AMR determinant is amplified. The resulting product is then treated with selected restriction enzymes that recognize particular nucleotide sequences. Differences in the resulting fragment patterns can indicate sequence variation, mutations, or genetic differences between isolates. In AMR studies, PCR-RFLP can assist in distinguishing resistance-associated variants and characterizing bacterial strains. Although newer sequencing technologies offer greater resolution, PCR-RFLP remains useful in specific molecular epidemiological investigations.

8. Restriction Fragment Length Polymorphism (RFLP)

Restriction Fragment Length Polymorphism (RFLP) is a molecular technique based on differences in DNA fragment lengths generated after digestion with specific restriction enzymes. Variations in DNA sequences can create or eliminate restriction sites, producing distinctive fragment patterns. In AMR investigations, RFLP can be used to compare bacterial isolates and investigate genetic variation associated with resistance determinants. It has historically contributed to molecular epidemiology and strain characterization. However, the technique is relatively labor-intensive and has largely been replaced by PCR-based assays and sequencing technologies that provide faster and more detailed information about resistance-associated genetic variation.

9. Single-Strand Conformational Polymorphism (SSCP)

Single-Strand Conformational Polymorphism (SSCP) is a molecular technique used to detect sequence variations based on differences in the three-dimensional structures adopted by single-stranded DNA molecules. Following amplification, DNA strands are separated and allowed to form secondary structures according to their nucleotide sequences. Even a single nucleotide substitution may alter the resulting conformation and therefore change its migration pattern during electrophoresis. In AMR research, SSCP can be used as a screening method for detecting mutations within resistance-associated genes. Samples showing different patterns may subsequently undergo sequencing for definitive identification of the underlying mutation.

10. Random Amplified Polymorphic DNA (RAPD)

Random Amplified Polymorphic DNA (RAPD) is a PCR-based technique that uses short, arbitrary primers to amplify multiple regions of bacterial genomic DNA. The resulting amplification patterns generate genetic fingerprints that can be compared between isolates. In AMR investigations, RAPD can assist in determining the genetic relatedness of resistant bacterial strains and identifying possible transmission or outbreak clusters. Unlike targeted PCR, RAPD does not specifically detect individual resistance genes. Instead, it provides information about overall genomic variation. Its reproducibility can be affected by reaction conditions, limiting its use compared with more standardized molecular typing and sequencing approaches.

11. Ligase Chain Reaction (LCR)

Ligase Chain Reaction (LCR) is a nucleic acid amplification technique that uses DNA ligase to join adjacent oligonucleotide probes when they are precisely complementary to a target DNA sequence. Repeated cycles of denaturation, hybridization, and ligation result in amplification of the target-dependent product. Because ligation requires highly accurate matching at the probe junction, LCR can provide considerable sequence specificity. In AMR applications, it can be used to detect particular resistance-associated mutations or genetic variants. Although PCR and modern sequencing methods are more widely employed, LCR remains relevant as a highly specific molecular detection principle.

12. Isothermal Amplification Methods

Isothermal amplification methods amplify nucleic acids at a constant temperature, eliminating the repeated heating and cooling cycles required by conventional PCR. Important examples include loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA). These techniques can rapidly amplify resistance-associated DNA and may be performed using relatively simple equipment. Their potential for integration into portable diagnostic systems makes them attractive for decentralized AMR detection, particularly where conventional laboratory infrastructure is limited. Isothermal assays can provide rapid results, although careful assay design is necessary to maintain specificity and prevent nonspecific amplification.

13. Next-Generation Sequencing (NGS)

Next-Generation Sequencing (NGS) refers to high-throughput sequencing technologies capable of analyzing millions of DNA fragments in parallel. In AMR detection, NGS can identify multiple resistance genes, genetic variants, mutations, and other genomic features within bacterial isolates or complex samples. Unlike targeted PCR, which searches for predefined genes, NGS can provide broader information and potentially identify unexpected resistance determinants. NGS is therefore valuable for investigating resistance mechanisms, bacterial evolution, and transmission. However, the technology requires appropriate computational infrastructure, quality-control procedures, and bioinformatic expertise for accurate interpretation of sequencing data.

14. Whole-Genome Sequencing (WGS)

Whole-Genome Sequencing (WGS) determines the nucleotide sequence of essentially the entire genome of a bacterial isolate. It provides comprehensive information about resistance genes, chromosomal mutations, plasmids, mobile genetic elements, virulence factors, and genetic relationships between isolates. In AMR surveillance, WGS can identify the molecular basis of resistance while simultaneously supporting investigation of transmission pathways and bacterial population structure. It is particularly valuable for outbreak investigations and epidemiological surveillance. The interpretation of WGS data depends on sequence quality, appropriate reference databases, and bioinformatic analysis capable of accurately identifying resistance determinants and their genomic context.

15. Nanopore Sequencing

Nanopore sequencing is a sequencing technology in which nucleic acid molecules pass through nanoscale pores, producing electrical signals that can be interpreted to determine their nucleotide sequence. A major advantage is the potential for real-time sequencing and relatively portable sequencing devices. In AMR surveillance, nanopore sequencing can rapidly characterize bacterial genomes and identify resistance-associated genes and mutations. Its portability makes it particularly attractive for field-based or resource-limited investigations. However, sequence accuracy, data analysis, and appropriate validation remain important considerations. Improvements in sequencing chemistry and computational methods continue to enhance its usefulness in AMR genomics.

16. Metagenomics for Antimicrobial Surveillance

Metagenomics involves the direct analysis of genetic material recovered from complex microbial communities without necessarily isolating and culturing individual bacterial species. In AMR surveillance, metagenomic sequencing can characterize the collection of resistance determinants, collectively known as the resistome, within samples such as wastewater, soil, food, clinical specimens, and other environmental sources. This approach can reveal resistance genes carried by both culturable and non-culturable microorganisms. Metagenomics therefore provides a broad perspective on the environmental and population-level distribution of AMR. However, interpretation can be challenging because assigning resistance genes to specific bacterial hosts may require additional analytical approaches.

17. DNA Microarray

DNA microarray technology uses large numbers of immobilized oligonucleotide probes arranged on a solid surface to detect multiple predefined genetic targets simultaneously. For AMR investigations, probes can be designed to recognize numerous resistance genes or gene variants within a single assay. Hybridization between sample DNA and complementary probes generates detectable signals corresponding to specific targets. Microarrays can therefore provide broad screening of known resistance determinants and are particularly useful when multiple genes must be investigated simultaneously. Their main limitation is that they generally depend on predefined targets and may not detect novel resistance genes that differ substantially from the included probes.

18. Fluorescence In Situ Hybridization (FISH)

Fluorescence In Situ Hybridization (FISH) uses fluorescently labelled nucleic-acid probes that bind specifically to complementary sequences within intact cells. The technique can identify particular microorganisms or genetic targets while maintaining information about their spatial location. In AMR research, FISH can be applied to detect specific bacterial populations or resistance-associated sequences and investigate their distribution within complex samples. Because the target can be visualized microscopically, FISH provides both molecular and cellular information. Its effectiveness depends on probe specificity and accessibility of the target sequence, and it generally requires appropriate fluorescence microscopy and technical expertise.

19. Mass Spectrometry-Based Methods

Mass spectrometry-based methods analyze molecules according to their mass-to-charge ratios and can provide detailed molecular profiles of microorganisms. Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) is widely used for rapid microbial identification and can also support investigation of certain resistance-associated biomarkers and mechanisms. Some approaches detect changes in proteins or other molecular products associated with antibiotic resistance. Mass spectrometry can provide rapid results and high-throughput microbial characterization, although interpretation may require reference spectral databases and specialized instrumentation. Its role in direct AMR gene detection remains more indirect than nucleic-acid-based techniques.

20. Bioinformatics Approaches and AMR Databases

Bioinformatics provides the computational framework required to interpret large amounts of molecular and genomic data generated by sequencing technologies. In AMR detection, bioinformatic pipelines analyze DNA sequences and compare them against curated antimicrobial resistance databases to identify known resistance genes, mutations, variants, and associated genetic elements. Computational analysis can also determine gene abundance, genomic location, potential mobility, and relationships between resistant isolates. Databases containing curated AMR determinants are therefore essential for accurate annotation. The reliability of results depends on database quality, sequence coverage, appropriate algorithms, and continuous updating as new resistance mechanisms are discovered.

21. Microfluidics

Microfluidics involves the manipulation of very small volumes of fluids through networks of microscopic channels. In AMR diagnostics, microfluidic systems can integrate sample preparation, bacterial detection, nucleic acid amplification, and signal measurement within compact platforms. Such integration can reduce reagent consumption and potentially shorten analytical turnaround time. Microfluidic devices may also facilitate development of portable or point-of-care AMR testing systems. Their ability to combine multiple analytical steps within a small device makes them attractive for rapid diagnostics. However, challenges involving sample preparation, device fabrication, assay standardization, and integration with complex clinical specimens remain important considerations.

22. Biosensors and Nanotechnology

Biosensors combine a biological recognition component with a transducer capable of converting a molecular interaction into a measurable signal. In AMR detection, recognition elements may target bacterial cells, nucleic acids, proteins, or resistance-associated molecules. Nanotechnology can improve biosensor performance through the use of nanoparticles, nanostructured surfaces, and other materials with enhanced electrical, optical, or catalytic properties. These approaches have potential for rapid, sensitive, and portable AMR detection. Their continued development may facilitate point-of-care testing, although issues related to reproducibility, validation, specificity, stability, and integration into routine diagnostic workflows must be addressed.

23. AST Optical Biosensors

AST optical biosensors detect changes in optical properties associated with bacterial growth, antibiotic exposure, molecular recognition, or biochemical reactions. Depending on their design, these systems may measure changes in fluorescence, absorbance, scattering, refractive index, or other optical signals. In antimicrobial susceptibility testing, optical biosensors can monitor bacterial responses to antibiotics more rapidly than conventional growth-based methods. Their potential for miniaturization and automation makes them attractive for rapid diagnostics. When combined with molecular recognition elements, optical biosensors may also support detection of specific resistance-associated targets, providing complementary information about bacterial identity and antimicrobial response.

24. AST Electrochemical Biosensors

AST electrochemical biosensors convert biological or chemical interactions into measurable electrical signals such as changes in current, voltage, impedance, or conductivity. In AMR applications, these devices can detect bacterial growth, metabolic changes, antibiotic responses, or specific molecular targets associated with resistance. Their relatively simple electronic readout systems and potential for miniaturization make them promising for rapid and portable antimicrobial susceptibility testing. Electrochemical biosensors can potentially reduce assay times and reagent requirements compared with conventional methods. Nevertheless, their analytical performance must be carefully validated to ensure adequate sensitivity, specificity, reproducibility, and clinical reliability.

25. Integration of CRISPR-Cas Systems with Aptamers

The integration of CRISPR-Cas systems with aptamers represents an emerging molecular strategy for highly specific AMR detection. CRISPR-Cas components can recognize complementary nucleic acid sequences, while aptamers are short nucleic-acid molecules selected for their ability to bind specific molecular targets. Combining these recognition mechanisms may enhance analytical specificity and enable detection of bacterial or resistance-associated targets at low concentrations. Such systems can potentially be incorporated into portable diagnostic platforms. Their future application in AMR surveillance may provide rapid and highly selective detection, although assay optimization, target specificity, signal generation, and clinical validation remain important requirements.

26. Machine Learning and Predictive Analytics

Machine learning and predictive analytics use computational algorithms to identify patterns within large and complex datasets. In AMR research, these approaches can integrate genomic sequences, resistance genes, bacterial characteristics, epidemiological information, and phenotypic susceptibility data. Models can be trained to recognize relationships between genetic features and antimicrobial susceptibility phenotypes, potentially supporting prediction of resistance to specific drugs. Machine learning can also assist in identifying previously unrecognized genomic patterns associated with resistance. However, predictive performance depends strongly on the quality, size, representativeness, and standardization of training datasets, as well as independent validation of computational models.

27. Whole-Genome and Targeted Sequencing-Based Variant Analysis

Sequencing-based variant analysis extends AMR detection beyond the identification of complete resistance genes. It enables the investigation of nucleotide substitutions, insertions, deletions, gene variants, promoter alterations, and other mutations that may contribute to antimicrobial resistance. Targeted sequencing can focus on specific resistance-associated regions, whereas whole-genome sequencing provides a broader assessment of genomic variation. Analysis of plasmids and other mobile genetic elements can also reveal the genetic context and potential transmission of resistance determinants. This high-resolution approach is valuable for molecular epidemiology, outbreak investigation, surveillance, and understanding the evolution of antimicrobial resistance.

28. Integrated Molecular Diagnostic Platforms

Integrated molecular diagnostic platforms combine multiple analytical technologies into a unified testing workflow. An AMR platform may incorporate sample preparation, nucleic acid extraction, amplification, molecular detection, sequencing, biosensing, and computational interpretation. Such integration aims to reduce manual handling, shorten turnaround time, and provide more comprehensive resistance information from a single specimen. These systems may be particularly valuable for rapid clinical decision-making and decentralized diagnostics. Integration with microfluidics, automation, and portable detection technologies can further improve accessibility. However, successful implementation requires rigorous analytical and clinical validation, quality control, standardization, and appropriate interpretation of molecular results.

References

He, Y., Zhao, J., Xu, X., Hou, X., Chen, Y., Shang, Y., & Xiang, X. (2026). Genotypic and phenotypic strategies to detect antibiotic resistance in foodborne pathogens along the food processing chain. Current Research in Food Science, 12, 101379.

Silva, C. P., Silva, C. L., Haq, I. U., et al. (2026). Phenotypic and genotypic antimicrobial resistance profiles of gram-positive cocci and non-fermenting gram-negative rods. Scientific Reports, 16, 22245.

Thoenen, L., Hummerjohann, J., Schwendimann, L., & Marti, E. (2025). Phenotypic and genotypic characterization of antibiotic-resistant bacteria from Swiss ready-to-eat meat products. Frontiers in Microbiology, 16, 1649307.

Trocado, N. D., de Moraes, M. S., Aveleda, L., Silva, C. R., & Marin, V. A. (2021). Phenotypic and genotypic detection of antibiotic-resistant bacteria in fresh fruit juices from a public hospital in Rio de Janeiro. Archives of Microbiology, 203(4), 1471–1475.

Yang, B., Xin, X., Cao, X., et al. (2024). Phenotypic and genotypic perspectives on detection methods for bacterial antimicrobial resistance in a One Health context: Research progress and prospects. Archives of Microbiology, 206, 409.

Rasheed, H., Ijaz, M., Ahmed, A., Javed, M. U., Shah, S. F. A., & Anwaar, F. (2023). Discrepancies between phenotypic and genotypic identification methods of antibiotic resistant genes harboring Staphylococcus aureus. Microbial Pathogenesis, 184, 106342.

Yamin, D., Uskoković, V., Wakil, A. M., Goni, M. D., Shamsuddin, S. H., Mustafa, F. H., Alfouzan, W. A., Alissa, M., Alshengeti, A., Almaghrabi, R. H., Fares, M. A. A., Garout, M., Al Kaabi, N. A., Alshehri, A. A., Ali, H. M., Rabaan, A. A., Aldubisi, F. A., Yean, C. Y., & Yusof, N. Y. (2023). Current and future technologies for the detection of antibiotic-resistant bacteria. Diagnostics, 13(20), 3246.

Liao, X., Deng, R., Warriner, K., & Ding, T. (2023). Antibiotic resistance mechanism and diagnosis of common foodborne pathogens based on genotypic and phenotypic biomarkers. Comprehensive Reviews in Food Science and Food Safety, 22, 3212–3253.

Shin, H., Kim, Y., Raza, S., Unno, T., Ryu, S.-H., & Hur, H.-G. (2022). Dynamics of genotypic and phenotypic antibiotic resistance in a conventional wastewater treatment plant in 2 years. Frontiers in Microbiology, 13, 898339.

Shivakumaraswamy, S. K., Deekshit, V. K., Vittal, R., Akhila, D. S., Mundanda, D. M., Mohan Raj, J. R., Chakraborty, A., & Karunasagar, I. (2019). Phenotypic & genotypic study of antimicrobial profile of bacteria isolates from environmental samples. Indian Journal of Medical Research, 149(2), 232–239.

Blumenscheit, C., Pfeifer, Y., Werner, G., John, C., Layer-Nicolaou, F., Schneider, A., Lasch, P., & Doellinger, J. (2026). Antibiotic resistance detection and concomitant species identification of ESKAPE pathogens by proteomics. Molecular & Cellular Proteomics, 25(4), 101539.

Alsuof, E. A., Alsayed, A. R., Zraikat, M. S., Khader, H. A., Hasoun, L. Z., Zihlif, M., Ata, O. A., Zihlif, M. A., Abu-Samak, M., & Al Maqbali, M. (2025). Molecular detection of antibiotic resistance genes using respiratory sample from pneumonia patients. Antibiotics, 14(5), 502.

Bergeron, M. G., & Ouellette, M. (1998). Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory. Journal of Clinical Microbiology, 36(8), 2169–2172.

Barenfanger J, Drakel C and Kacich (1999). Clinical and Financial Benefits of Rapid Bacterial Identification and Antimicrobial Susceptibility Testing. Journal of Clinical Microbiology, 37(5):1415-1418.

Madigan M.T., Martinko J.M., Dunlap P.V and Clark D.P (2009). Brock Biology of Microorganisms, 12^th edition. Pearson Benjamin Cummings Inc, USA.

Mahon C. R, Lehman D.C and Manuselis G (2011). Textbook of Diagnostic Microbiology. Fourth edition. Saunders Publishers, USA.

National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial susceptibility testing. 8^th Informational Supplement. M100 S12. National Committee for Clinical Laboratory Standards, 2002. Villanova, Pa.

Washington J.A (1993). Rapid antimicrobial susceptibility testing: technical and clinical considerations. Clin Microbiol Newsl, 15:153–155.